These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 22727681)

  • 21. Molecular and serological evaluation of surface antigen negative hepatitis B virus infection in blood donors from Venezuela.
    Gutiérrez C; Devesa M; Loureiro CL; León G; Liprandi F; Pujol FH
    J Med Virol; 2004 Jun; 73(2):200-7. PubMed ID: 15122793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers.
    Kao JH; Chen PJ; Lai MY; Chen DS
    J Med Virol; 2004 Mar; 72(3):363-9. PubMed ID: 14748059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid early HDV RNA decline in the peripheral blood but prolonged intrahepatic hepatitis delta antigen persistence after liver transplantation.
    Mederacke I; Filmann N; Yurdaydin C; Bremer B; Puls F; Zacher BJ; Heidrich B; Tillmann HL; Rosenau J; Bock CT; Savas B; Helfritz F; Lehner F; Strassburg CP; Klempnauer J; Wursthorn K; Lehmann U; Manns MP; Herrmann E; Wedemeyer H
    J Hepatol; 2012 Jan; 56(1):115-22. PubMed ID: 21762665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nucleic acid testing to detect HBV infection in blood donors.
    Stramer SL; Wend U; Candotti D; Foster GA; Hollinger FB; Dodd RY; Allain JP; Gerlich W
    N Engl J Med; 2011 Jan; 364(3):236-47. PubMed ID: 21247314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis D virus infection in a hyperendemic area of chronic hepatitis B virus infection: the Taiwan experience.
    Chen DS; Lai MY; Chen PJ; Sheu JC; Yang PM; Sung JL
    Prog Clin Biol Res; 1991; 364():75-80. PubMed ID: 2020724
    [No Abstract]   [Full Text] [Related]  

  • 26. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease.
    Cacciola I; Pollicino T; Squadrito G; Cerenzia G; Orlando ME; Raimondo G
    N Engl J Med; 1999 Jul; 341(1):22-6. PubMed ID: 10387938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum hepatitis B surface antigen monitoring in long-term lamivudine-treated hepatitis B virus patients.
    Gramenzi A; Loggi E; Micco L; Cursaro C; Fiorino S; Galli S; Gitto S; Galli C; Furlini G; Bernardi M; Andreone P
    J Viral Hepat; 2011 Oct; 18(10):e468-74. PubMed ID: 21914065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Serial study of detection of serum HBV-DNA in chronic hepatitis B patients with clearance of HBs antigen followed by emergence of anti-HBs antibody].
    Kato J; Hasegawa K; Hayashi N
    Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):569-73. PubMed ID: 12442446
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor.
    Knöll A; Boehm S; Hahn J; Holler E; Jilg W
    J Viral Hepat; 2007 Jul; 14(7):478-83. PubMed ID: 17576389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virological profiles in hepatitis B virus inactive carriers: monthly evaluation in 1-year follow-up study.
    Cacciola I; Spatari G; Pollicino T; Costantino L; Zimbaro G; Brancatelli S; Fenga C; Caccamo G; Squadrito G; Raimondo G
    Liver Int; 2005 Jun; 25(3):555-63. PubMed ID: 15910493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Change in serum hepatitis B surface antigen level and its clinical significance in treatment-naïve, hepatitis B e antigen-positive patients receiving entecavir.
    Jung YK; Kim JH; Lee YS; Lee HJ; Yoon E; Jung ES; Hong SK; Joo MK; Yeon JE; Park JJ; Kim JS; Bak YT; Byun KS
    J Clin Gastroenterol; 2010 Oct; 44(9):653-7. PubMed ID: 20216430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy.
    Filippini P; Coppola N; Pisapia R; Scolastico C; Marrocco C; Zaccariello A; Nacca C; Sagnelli C; De Stefano G; Ferraro T; De Stefano C; Sagnelli E
    AIDS; 2006 Jun; 20(9):1253-60. PubMed ID: 16816553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A reduction study of seroconversion of HBsAg in chronic hepatitis B patients with HBeAg positive by combination treatment with interferon and lamivudine].
    Yu SL; Qin LY; Wang C; Yu LJ; Guo CY; Wang YZ
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):472-3. PubMed ID: 19567034
    [No Abstract]   [Full Text] [Related]  

  • 34. A molecular analysis of viral persistence in surface antigen-negative chronic hepatitis B.
    Kato J; Hasegawa K; Torii N; Yamauchi K; Hayashi N
    Hepatology; 1996 Mar; 23(3):389-95. PubMed ID: 8617416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of correlation between hepatitis B surface antigen and hepatitis B virus DNA levels in blood donors.
    Allain JP; Sarkodie F; Candotti D; Opare-Sem O
    Transfusion; 2005 Jun; 45(6):1039-40. PubMed ID: 15935007
    [No Abstract]   [Full Text] [Related]  

  • 36. The importance of being earnest: following up a low level hepatitis B surface antigen (HBsAg) result.
    De Gascun CF; Fraher M; Crean M; Connell J; Hall WW
    J Clin Virol; 2010 Oct; 49(2):79-81. PubMed ID: 20570554
    [No Abstract]   [Full Text] [Related]  

  • 37. Hepatitis B surface antigen monitoring and management of chronic hepatitis B.
    Sonneveld MJ; Zoutendijk R; Janssen HL
    J Viral Hepat; 2011 Jul; 18(7):449-57. PubMed ID: 21692954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Quantitative analysis of hepatitis B surface antigen as a clinical marker].
    Nakamura E; Kakuda H; Matsuura K; Sugauchi F; Shinkai N; Tanaka Y
    Rinsho Byori; 2011 Sep; 59(9):838-43. PubMed ID: 22111300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylaxis of hepatitis B virus recurrence after liver transplantation.
    Testino G; Borro P; Sumberaz A
    J Gastrointestin Liver Dis; 2009 Jun; 18(2):139-41. PubMed ID: 19565040
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacology, clinical efficacy and safety of lamivudine in hepatitis B virus infection.
    Kumar M; Sarin SK
    Expert Rev Gastroenterol Hepatol; 2008 Aug; 2(4):465-95. PubMed ID: 19072396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.